Partnerships and pathways of dissemination: The National Institute on Drug Abuse—Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network
Martino S, Brigham GS, Higgins C, Gallon S, Freese TE, Albright LM, Hulsey EG, Krom L, Storti SA, Perl H, Nugent CD, Pintello D, Condon TP. Partnerships and pathways of dissemination: The National Institute on Drug Abuse—Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network. Journal Of Substance Use And Addiction Treatment 2010, 38: s31-s43. PMID: 20307793, PMCID: PMC2855549, DOI: 10.1016/j.jsat.2009.12.013.Peer-Reviewed Original ResearchMeSH KeywordsBuprenorphineClinical Trials as TopicCommunity Health ServicesHumansInformation DisseminationInterview, PsychologicalMotivationNarcotic AntagonistsNational Institute on Drug Abuse (U.S.)Public-Private Sector PartnershipsSubstance Abuse Treatment CentersSubstance-Related DisordersTechnology TransferUnited StatesConceptsClinical Trials NetworkCommunity treatment programsAddiction Technology Transfer CentersNational Drug Abuse Treatment Clinical Trials NetworkTreatment programTrials NetworkNational InstituteCTN trialsPathways of disseminationIntegral roleMotivational interviewingImplementation supportTrialsRegional trainersWidespread trainingDissemination pathwaysAbuseBuprenorphinePathway